idiopathic PD

Related by string. * Idiopathic : idiopathic pulmonary fibrosis IPF . idiopathic dilated cardiomyopathy . addressing idiopathic pulmonary . idiopathic thrombocytopenic purpura ITP . Idiopathic Thrombocytopenic Purpura ITP . aortic stenosis idiopathic hypertrophic . chronic idiopathic urticaria CIU / PS . Ping . Ps . Per . ping . p. : P aul . Per Cent Stake . & P . Ten Per Cent . Ping An . P TSX * *

Related by context. Frequent words. (Click for all words.) 63 sensory neuropathy 58 extrapyramidal symptoms 58 parkinsonism 58 onset seizures 57 concomitant medications 57 cardiac dysfunction 57 receiving VELCADE 57 cerebrovascular events 57 osteoarthritis rheumatoid arthritis 57 hypercalcemia 57 nonfatal MI 57 hyperactivity impulsivity 57 hematologic toxicity 56 amnestic mild cognitive impairment 56 dyskinesias 56 fatigue shortness 56 neurologic symptoms 56 carotid stenosis 56 clinically meaningful improvement 55 allodynia 55 NYHA Class II 55 % CI #.#-#.# [007] 55 airflow obstruction 55 Chronic fatigue 55 infarcts 55 PsA 55 generalized anxiety disorder GAD 55 impaired renal 55 chlorambucil 54 relapsing remitting 54 QTc prolongation 54 bone marrow suppression 54 atherothrombosis 54 cerebrovascular accident 54 Baseline characteristics 54 plus gemcitabine 54 daytime drowsiness 54 thromboembolic 54 Parkinsonism 54 subclinical hypothyroidism 54 Alzheimer Disease AD 54 hypoxemia 54 rheumatoid factor 54 claudication 54 cerebral ischemia 54 pg ml 54 daunorubicin 53 Parkinson disease PD 53 Exclusion criteria 53 Obstructive sleep apnea 53 muscle rigidity 53 epistaxis 53 Pulmonary hypertension 53 intermittent claudication 53 hypocalcemia 53 left ventricular dysfunction 53 neuropsychiatric symptoms 53 affective disorders 53 juvenile idiopathic arthritis 53 adrenal insufficiency 53 confidence interval #.#-#.# 53 experimentally induced 53 demyelinating disease 53 hypokalemia 53 angina chest 53 fasting plasma glucose FPG 53 inattention hyperactivity 53 primary hypercholesterolemia 52 neurological disorder characterized 52 Withdrawal symptoms 52 prolactin levels 52 cerebral infarction 52 ventricular arrhythmia 52 NYHA Class III 52 recurrent seizures 52 nausea fatigue 52 paresthesia 52 lactic acidosis 52 brain lesions 52 Abdominal pain 52 Adverse events 52 metastatic bone 52 interquartile range 52 Secondary endpoints include 52 optic neuropathy 52 left ventricular systolic 52 chronic neurological disorder 52 hypersomnia 52 fibromyalgia syndrome 52 agranulocytosis 52 muscle spasticity 52 acute exacerbations 52 nasopharyngitis 52 % CI #.#-#.# [003] 52 myelodysplastic syndrome MDS 52 renal dysfunction 52 metabolic acidosis 52 ischaemia 52 % CI #.#-#.# [006] 52 renal toxicity 52 fasting insulin

Back to home page